COMMUNIQUÉS West-GlobeNewswire

Ultragenyx Announces Positive Topline Data from Ongoing Long-Term Extension Study of UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders
22/01/2019
Reductions in Major Clinical Events Sustained After an Additional 78 Weeks of UX007 Treatment Additional 20 Patients Naïve to UX007 Also Demonstrated Meaningful Reductions in Major Clinical Events with Treatment Company [...]
Advantis Corp. Set for Major Expansion in 2019
22/01/2019
Newport Beach, CA, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ADVANTIS CORPORATION (OTC PINK: ADVT) CEO, Darren Cherry, recently took a moment to reflect on Advantis’ 2018 progress, and provided a look ahead [...]
Biome Secures Purchase Order with NSLC & Delivers First Shipment-- CFN Media
22/01/2019
SEATTLE, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Innovation Pharmaceuticals Announces Clinical Development Plans for Oral Brilacidin for Inflammatory Bowel Disease
22/01/2019
BEVERLY, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, is pleased to announce plans to initiate in 2019 a clinical trial of [...]
fMRI Data from Clinical Trial Demonstrate a Proposed Mechanism of Action for the Efficacy of Vayarin® Plus in Adults with ADHD
22/01/2019
Study Abstract Presented at the 2019 APSARD Annual Meeting in Washington, DC COLUMBIA, Md., Jan. 22, 2019 (GLOBE NEWSWIRE) -- VAYA™ Pharma, Inc. ( VAYA™ ), a division of Frutarom, Inc, and leader in developing specialty [...]
Allscripts to release fourth-quarter and full-year 2018 financial results February 21
22/01/2019
CHICAGO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) will report its financial results for the three months and full year ended December 31, 2018, after the close of stock [...]
Allscripts offers free pharmacogenomics testing to U.S.-based associates
22/01/2019
Program will help individuals understand the efficacy and safety of specific medications CHICAGO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions (NASDAQ: MDRX) today launched a precision medicine [...]
HempAmericana Commences Full-Scale Production with Significant Purchase Order for CBD Distillate
22/01/2019
NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is pleased to announce a significant Purchase Order for CBD Distillate from a major [...]
Cocrystal Pharma Provides Update on Clinical Development Program Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C Virus
22/01/2019
- Hepatitis C program designed to develop ultra-short treatment for hepatitis C virus (HCV) consisting of CC-31244, an oral, potent, broad-spectrum non-nucleoside inhibitor, as a part of combination therapy to include [...]
Vystar® Begins Soft Launch of Vytex® Cloud Bed-in-a-Box via Rotmans
22/01/2019
Luxuriously soft supportive comfort, resilience and breathability Thicker mattress and the ultimate plush covering 6 sizes, 3 levels of softness World’s purest, naturally anti-microbial, odor-free and virtually allergen [...]
Tower One Announces Debt Financing and Update on Tower Deployments
22/01/2019
VANCOUVER, British Columbia, Jan. 22, 2019 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) is pleased to announce it has raised $966,300 CAD by way [...]
InspireMD Announces Results from Initial Clinical Study of The CGuard™ Embolic Prevention System (EPS) with SmartFit™ Technology
22/01/2019
“Initial Clinical Study of the New CGuard™ EPS MicroNet® Covered Carotid Stent: ‘One Size Fits All’” presented at the LINC 2019 Congress TEL AVIV, Israel, Jan. 22, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American [...]
PetMed Express D/B/A 1-800-PetMeds Announces Its Third Quarter Financial Results and Declares Its $0.27 Per Share Dividend
22/01/2019
DELRAY BEACH, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended December 31, 2018. Net sales were $60.1 million for both the quarters [...]
HealthLynked signs Definitive Agreement to Acquire HCFM, Adding Significant Revenue to its Health Services Division
22/01/2019
NAPLES, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp (OTCQB: HLYK), a leading digital healthcare business, announced today that it has entered into a definitive agreement to acquire Hughes Center for [...]
Spectral Announces Distribution Agreement for its Proprietary CRRT Machine
22/01/2019
TORONTO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]
Attune Pharmaceuticals Announces Positive Phase 1 Results for ATN-249, an Oral Plasma Kallikrein Inhibitor for the Treatment of HAE
22/01/2019
NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Attune Pharmaceuticals, a biotechnology company focused on the discovery and development of novel oral small molecule therapeutics for treatment of rare diseases, today [...]
Apollomics, Inc. Strengthens Leadership with Key Hires
22/01/2019
Wilson W. Cheung, CPA appointed Chief Financial Officer Debra L. Thoma Vallner, PhD, MBA named Senior Vice President, Development Operations FOSTER CITY, Calif. and HANGZHOU, China, Jan. 22, 2019 (GLOBE NEWSWIRE) -- [...]
DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke,” in the Journal Therapeutic Advances in Neurological Disorders
22/01/2019
MINNEAPOLIS, Jan. 22, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (NASDAQ:DMAC) announces the publication of a paper titled “ Human Tissue Kallikrein In The Treatment Of Acute Ischemic Stroke ” in the peer [...]
Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of Transfusion-Dependent Beta-Thalassemia in Nature Medicine
22/01/2019
Publication Highlights Encouraging Evidence of OTL-300’s Safety and Efficacy in Transfusion-Dependent Beta-Thalassemia Patients BOSTON and LONDON, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (NASDAQ: ORTX), a [...]

Pages